Healthcare Industry News: IMRT
News Release - October 4, 2006
VA Contracts with Elekta and IMPAC for Radiation Oncology Systems and Healthcare IT SolutionsATLANTA, Oct. 4 (HSMN NewsFeed) -- The Department of Veterans Affairs renewed its contract with Elekta, Inc. for radiation oncology products for one year with the option of three additional extension years.
The contract includes not only the Department of Veterans Affairs (VA), but also the Department of Defense and other federal agencies (also known as Other Government Agencies or OGSs) within the 50 states, Washington, D.C. and Puerto Rico.
The contract covers Elekta's advanced digital linear accelerators, capable of intensity modulated radiation therapy (IMRT) and 3D X-ray Volume Imaging for image guided radiation therapy (IGRT), developed to address the problems of organ movement and patient set-up uncertainties in radiation therapy.
IMPAC Medical Systems, Inc., an Elekta company, received a contract for the company's oncology-specific healthcare IT solutions for the same period of time. The IMPAC contract includes Multi-ACCESS(TM) and MOSAIQ(TM) solutions, which fully integrate with all major treatment systems to improve patient outcomes and expedite workflow, benefiting both the patient and the treatment center.
Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group became the world's largest supplier of oncology software.
The VA provides federal benefits to eight million veterans, their family members and survivors. With a work force of more than 225,000 employees, the VA is the largest civilian department in the federal government.
Elekta is an international medical-technology group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Elekta's systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approximately 2,000 employees, Elekta's corporate headquarters are located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry.
With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency and quality patient care. For more information, visit www.impac.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.